Issues related to domestic manufacturing of essential medicines; issues related to access to and availability of generic medicines, generally.
2026 · 3rd Quarter (July 1 - Sep 30)
FRESENIUS KABI USA, LLC
Filed by DB3, LLC (FKA THE DASCHLE GROUP).
Open official filingSource-reported fields
Filing overview
- Type
- Registration
- Posted
- Jul 28, 2026
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- DB3, LLC (FKA THE DASCHLE GROUP)
- Client
- FRESENIUS KABI USA, LLC
- Filing UUID
- da9a6a87-1718-43d0-a935-b68a3346eec4
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.